Standard
WHO Welcomes Landmark UK Clinical Trial Results Showing Dexamethasone Reduces COVID-19 Mortality in Critically Ill Patients
GENEVA — The World Health Organization has officially welcomed initial clinical trial results from the United Kingdom demonstrating that the widely used corticosteroid dexamethasone can be lifesaving for patients suffering from critical forms of COVID-19. According to preliminary findings shared directly with the global health agency, the treatment significantly reduces mortality rates among hospitalized individuals…
